A human study to evaluate tolerance and safety of D-Allulose

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0003989

Enrollment

Registered

2019-05-27

Start date

2019-06-17

Completion date

Unknown

Last updated

2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : Subjects take placebo or D-allulose twice a day for 16 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Subject who voluntarily agrees to participate and signs in informed consent form 2) Healthy people over 20 years old.

Exclusion criteria

Exclusion criteria: 1) Subject with diseases and past medical history 2) Administration of drugs, dietary supplement, oriental medicine within 4 weeks before the first visit 3) Subjects with hypersensitivity to test materials 4) Participation in other human study within 4 weeks before the first visit 5) Pregnant or lactating women

Design outcomes

Primary

Measure	Time frame
Hematological test(WBC, RBC, Hb et al.);Blood chemical test(ALP, BUN, creatinine et al.);Urine test(pH, protein,glucose et al.)	—

Secondary

Measure	Time frame
Adverse events;Vital signs	—

Countries

Korea, Republic of

Contacts

Public ContactMinju KIM

Seoul Metropolitan Government Seoul National University Boramae Medical Center

dfnimj86@gmail.com+82-2-870-2686

Outcome results